Document ypBKJ8qzeRm0axdzn4rjqyQG2

March 24, 1966 Bernard B. Brodie, Ph.D. Chief, Laboratory of Chemical Pharmacology National Keart Institute National Institutes of Health Public Health Service Bethesda, Maryland 20014 Dear Doctor Brodie: Having returned to my desk some weeks ago, I have now the opportunity of catching up with my correspondence, and I note with thanks your response of September 8 to my letter concerning the alleged carcinogenecity of tetraethyllead. I think it unlikely that many persons examined the references in your article with sufficient care to note the statement, but I wonder, in view of the fact that the unexpected often happens, whether some correction of the statement is in order. It may be that this would excite more of a problem than it would prevent, but I am mindful of the authority that is vested in the written word, and how frequently this operates in medico-legal matters. Incidentally, this is hardly likely to make any trouble for me, but it slight well create a serious issue in the tetraethyllead (antiknock) industry, which is often, and even now, under examination in other matters. I wonder, therefore, if an unobtrusive note in SCIENCE, for the record, would not be appropriate. Sincerely yours, RAK:wp Robert A. Kehoe, M.D. K 0019971